Orion <10K Frydenberg Mark None Gillessen Silke AAA International <10K to hospital Astellas uncompensated <10K to hospital <10K to hospital Squibb <10K to hospital Clovis <10K to hospital CureVac <10K to hospital Ferring <10K to hospital <10K to hospital Janssen <10K to hospital MaxiVax SA <10K to Consultant <10K to hospital Roche uncompensated <10K to hospital Sanofi uncompensated uncompensated ESSA Pharmaceuticals uncompensated Nectar uncompensated ProteoMediX Janssen <10K to hospital Novartis <10K to hospital Gleave Martin Janssen <10K <10K OncoGenex 10-50K 10-50K <10K Astellas <10K <10K <10K <10K AstraZeneca <10K Halabi Susann none Heidenreich Axel Amgen <10K Astellas <10K <10K 10-50K <10K Dendreon <10K Ferring <10K <10K <10K Janssen <10K <10K <10K Sanofi <10K <10K 10-50K <10K Higano Celestia Aptevo >50K to institution Aragon >50K to institution Asana Biosciences <10K <10K AstraZeneca >50K to institution
Orion <10K Frydenberg Mark None Gillessen Silke AAA International Astellas Squibb Clovis CureVac Ferring Janssen MaxiVax SA Roche Sanofi ESSA Pharmaceuticals Nectar ProteoMediX Janssen Novartis uncompensated <10K to hospital uncompensated uncompensated <10K to hospital <10K to hospital <10K to hospital <10K to hospital <10K to hospital <10K to hospital <10K to hospital <10K to hospital <10K to hospital <10K to hospital <10K to Consultant <10K to hospital <10K to hospital uncompensated uncompensated uncompensated Gleave Martin Janssen OncoGenex Astellas AstraZeneca <10K 10-50K <10K <10K 10-50K <10K <10K <10K <10K <10K Halabi Susann none Heidenreich Axel Amgen Astellas Dendreon Ferring Janssen Sanofi <10K <10K <10K <10K <10K <10K <10K <10K <10K <10K 10-50K 10-50K <10K <10K <10K <10K Higano Celestia Aptevo Aragon Asana Biosciences AstraZeneca <10K >50K to institution >50K to institution >50K to institution <10K
1-s2.0-S0302283817304979-mmc4.docx